See the DrugPatentWatch profile for Jornay
The generic name for Jornay PM is methylphenidate hydrochloride [1].
What is Jornay PM used for?
Jornay PM is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in individuals aged 6 years and older [1]. It is a central nervous system stimulant [1].
How does Jornay PM work?
Jornay PM is designed with a dual-pulse delivery system. It releases an initial dose of methylphenidate in the morning and a second release in the afternoon. This delivery mechanism aims to provide symptom control throughout the day and into the evening [2].
When does the patent for Jornay PM expire?
Information regarding specific patent expiry dates for Jornay PM can be found on DrugPatentWatch.com [3]. Generally, pharmaceutical patents protect the drug for a certain period, after which generic versions may become available.
Who manufactures Jornay PM?
Jornay PM is manufactured by Ironshore Pharmaceuticals [1].
What are the potential side effects of Jornay PM?
Common side effects of Jornay PM can include decreased appetite, insomnia, anxiety, weight loss, nausea, and headache [1]. Serious side effects may involve cardiovascular issues, psychiatric problems, and growth suppression. Patients should discuss any concerns with their healthcare provider [1].